Nike, Alpine Immune Sciences rise premarket; CarMax, Robinhood and Regeneron fall

Baird Reviews Amazon.com (AMZN) Shareholder Letter

Baird analyst Colin Sebastian reiterated an Outperform rating and $205.00 price target on Amazon.com (NASDAQ: AMZN)/

The analyst comments "Fast deliveries, accelerating AWS growth, and increasing margins. This is what we believe would be a reasonable expectation for Amazon this year after reading... More

CarMax (KMX) PT Lowered to $73 at RBC Capital

RBC Capital analyst Steven Shemesh lowered the price target on CarMax (NYSE: KMX) to $73.00 (from $83.00) while maintaining a Outperform rating.

The analyst comments "4Q results were noisy. We were encouraged by retail comp units improving to ~flat (from -4% in... More

CarMax (KMX) PT Lowered to $74 at Evercore ISI

Evercore ISI analyst Michael Montani lowered the price target on CarMax (NYSE: KMX) to $74.00 (from $85.00) while maintaining a In Line rating.

The analyst comments "CarMax remains focused on profitable share gain for the long term, while investing to build out higher growth and... More

Rent the Runway Inc (RENT) PT Lowered to $21 at Jefferies

Jefferies analyst Ashley Helgans lowered the price target on Rent the Runway Inc (NASDAQ: RENT) to $21.00 (from $53.00) while maintaining a Buy rating.

The analyst comments "Q4 sales and EBITDA beat cons. Initial FY24 guide was below on sales at the midpoint... More

With Amazon.com (AMZN) at New Record Highs, Jefferies Comments on Earlier-Issued Letter to Shareholders

Jefferies analyst Brent Thill reiterated a Buy rating and $225.00 price target on Amazon.com (NASDAQ: AMZN).

The analyst comments "In AMZN's annual letter to shareholders they highlighted achieving record delivery speeds while also lowering the cost to serve on a per... More

Amazon (AMZN) Hits New Record High, Surpasses Previous High in July 2021

Amazon (NASDAQ: AMZN) Hits New Record High, Surpasses Previous High Hit in July 2021

RBC on Regeneron Pharma (REGN):'The Buying Opportunity Many Have Been Looking For, With Overdone DOJ Downside On Top Of Recent Weakness'

RBC Capital analyst Brian Abrahams reiterated a Sector Perform rating and $1,189.00 price target on Regeneron Pharma (NASDAQ: REGN)

The analyst comments "We note that DOJ has filed a complaint against REGN, accusing the company of fraudulently inflating Medicare reimbursement rates for Eylea. To our read, this is in regard to REGN's practice in reimbursing credit card transaction fees to distributors that occurred when physicians purchased the product using credit cards. While we do not know what the exact damages would be in case of potential settlement, given the complaint highlighting $250M in... More

CarMax (KMX) PT Lowered to $70 at CFRA

CFRA analyst Garrett Nelson lowered the price target on CarMax (NYSE: KMX) to $70.00 (from $75.00) while maintaining a Hold rating.

The analyst comments "We lower our 12-month price target by $5 to $70, based on a FY 26 (Feb.) P/E of 17.5x, a justified... More

Nike (NKE) raised to buy at BofA, sees Olympics as catalyst

Nike (NYSE: NKE) was upgraded to Buy from Neutral at Bank of America on Thursday, with the firm lifting its price target for the stock to $113 from $110 per share.

The bank said estimates are bottoming and look achievable, while the stock's multiple has compressed.

"Nike is taking bold steps to transform,... More